Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 3, 1999

View Archived Issues

Antisoma Partners With Abbott For Cancer Product In Phase III

MHC Genome Aids Research Into Cause Of Many Diseases

Sugen Founder Criticizes UK Measures In Containing Costs

DrugAbuse Sciences Raises $22.4M In Private Financing

GenProfile Plans To Exploit Advances In Gene Analysis

Genomics Company Genfit Plans On Public Partnerships

Vanguard Medica Set Back As FDA Asks For More Data

EU Puts Off Decisions On Three Biotech Applications

Teva Offers Novopharm $700M For All Except Biotech Division

Cortecs Reduces R&D Focus As Part Of Change In Strategy

European Investment Bank Plans First Action In Biotech

NicOx Reduces Initial Offering After Doubt From U.S. Investors

Qiagen Among Companies Joining E-Commerce Alliance

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...